From: Detection of gene pathways with predictive power for breast cancer prognosis
Pathway | Size | P-value |
---|---|---|
Glutamate metabolism | 5 | 2.22E-16 |
Amyotrophic lateral sclerosis (ALS) | 6 | 5.55E-15 |
Colorectal cancer | 19 | 2.26E-13 |
Small cell lung cancer | 27 | 1.15E-12 |
Streptomycin biosynthesis | 2 | 1.95E-12 |
Cell cycle | 36 | 3.10E-12 |
Prion disease | 4 | 3.37E-12 |
Renin-angiotensin system | 2 | 8.99E-12 |
Nicotinate and nicotinamide metabolism | 5 | 1.13E-11 |
Circadian rhythm | 2 | 4.24E-11 |
Glycerophospholipid metabolism | 14 | 4.36E-11 |
Prostate cancer | 20 | 1.21E-10 |
Apoptosis | 27 | 4.67E-10 |
Oxidative phosphorylation | 15 | 7.32E-10 |
Synthesis and degradation of ketone bodies | 2 | 8.75E-10 |
D-Glutamine and D-glutamate metabolism | 2 | 1.78E-09 |
Focal adhesion | 49 | 2.07E-09 |
Dentatorubropallidoluysian atrophy (DRPLA) | 5 | 2.24E-09 |
Renal cell carcinoma | 17 | 5.06E-09 |
Neurodegenerative Disorders | 10 | 5.56E-09 |